Tripos Releases Newest Version of Discovery 360 – Its Powerful, Enterprise-Wide, Pharmaceutical Research Software

ST. LOUIS–(BUSINESS WIRE)–Tripos®, a leading provider of drug discovery informatics products and services, today announced the release and general availability of Discovery 360 (D360) Version 5.5. This newest release expands on the established and robust data access and analysis capabilities of previous D360 versions, providing significant new automation, communication and data visualization capabilities to assist scientists in their data workflows. The D360 client is also now available for MAC platforms.

According to Tripos’ Chief Executive Officer, Jim Hopkins, “D360 is simply the most cost effective way to improve research effectiveness, by providing scientists access to all their data. Scientists using D360 are better informed and can more broadly and deeply understand the information about their research project from the scientific detail to the logistical necessities – D360 represents a revolutionary improvement in how information is employed in research.”

Adoption of D360 has continued to grow in the scientific community, with new companies ranging from small biotech to large pharmaceutical organizations deploying the solution to their scientists. Straightforward integration with IDBS’s ActivityBase allows rapid and straightforward deployment on that architecture, simplifying and expanding data access capabilities for a wide spectrum of organizations.

Tripos’ Discovery 360 Product Manager, David R. Lowis, D.Phil., says, “D360 is designed to make scientific data workflows straightforward and effective in moving a scientist from asking questions to taking the appropriate action. In this release, we have enhanced the automation and collaboration aspects of the product to best leverage all the intellectual assets of research teams and create self-supporting communities of users.” He adds, “All data manipulations, analysis, and dataset visualization can now be automated, allowing users ‘one click access’ to the view of their data they need for their workflow. We have added annotation tools to D360, so users can easily share their progress on experiments with project teams. With this latest version, they can also incorporate data and information in their analyses that may not be available in corporate data systems, further improving communication and decision-making.”

About Tripos

Tripos, a Certara™ Company, is a global leader in innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Established in 1979, Tripos was the first company to bring scientific computational drug discovery capabilities to the pharmaceutical, chemical and food design industries, and today helps a broad range of companies and research facilities accelerate the identification and optimization of new compounds that have the potential to become marketed drugs, foods, flavorings and fragrances. Headquartered in St. Louis, Missouri, Tripos serves more than 1,000 customers spanning over 46 countries.

About Certara

Certara is dedicated to improving human health through a broad spectrum of products and services, from molecular discovery to clinical research. Formed in 2008, Certara unites Tripos (www.tripos.com) and Pharsight Corporation (www.pharsight.com). Tripos provides innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Pharsight provides software and scientific services to improve productivity and decision-making in clinical drug development. Certara focuses on reducing the barriers between the phases of research to speed discoveries in chemistry, and enabling pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products.